BIOCARTIS GROUP NV |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.29 EUR | +1.05% |
|
-.--% | -.--% |
Chart calendar Biocartis Group NV
5609f0719e127ffa6ca14.FDk0frJNtH7cEXwGxTrPTqiKRZ2mTNQDJB64LgrxBLY.IHZ3Lvo3xUnqdy5IhHGWC-LtJPHTBaZac23OGnLDMfxGUVof832HKbNnRA~89f47d6f7c0e68ab432ec8a8504c4bc1
Upcoming events on Biocartis Group NV
Past events on Biocartis Group NV
| 09/11/2023 11:30 am | Q3 2023 Sales and Revenue Release |
| 26/09/2023 06:00 pm | Q2 2023 Earnings Call |
| 26/09/2023 10:30 am | Q2 2023 Earnings Release |
| 12/05/2023 05:30 pm | Annual General Meeting |
| 20/04/2023 11:00 am | Q1 2023 Sales and Revenue Release |
| 23/02/2023 07:00 pm | FY 2022 Earnings Call |
| 23/02/2023 11:30 am | FY 2022 Earnings Release |
| 15/11/2022 | Jefferies London Healthcare Conference |
| 14/11/2022 06:30 pm | Extraordinary Shareholders Meeting |
| 10/11/2022 11:30 am | Q3 2022 Sales and Revenue Release |
| 02/11/2022 | Association for Molecular Pathology Meeting |
| 27/10/2022 05:30 pm | Extraordinary Shareholders Meeting |
| 21/09/2022 | LifeSci Partners HealthTech Symposium |
| 15/09/2022 | KBC Life Sciences Conference |
| 01/09/2022 06:00 pm | Interim 2022 Earnings Call |
| 01/09/2022 10:30 am | Interim 2022 Earnings Release |
| 13/05/2022 05:30 pm | Annual General Meeting |
| 10/05/2022 | Berenberg Diagnostics Conference |
| 21/04/2022 11:00 am | Q1 2022 Sales and Revenue Release |
| 24/02/2022 07:00 pm | FY 2021 Earnings Call |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 28,7 30,4 -5.65% | 37,7 43,9 -14.06% | 55,6 44,8 24.04% | 54,9 49,3 11.47% | 0,00 |
|
EBITDA Million EUR | Released Forecast Spread | -42,6 -41,6 -2.48% | -45,9 -40,6 -12.96% | -37,1 -45,2 17.84% | -52,8 -57,1 7.45% | 0,00 |
|
EBIT Million EUR | Released Forecast Spread | -46,9 -47,1 0.43% | -55,6 -43,5 -27.97% | -46,9 -48,1 2.47% | -62,6 -67,0 6.5% | 0,00 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -48,3 -50,8 4.93% | 0,00 0,00 - | -63,2 -57,2 -10.42% | -71,7 -80,0 10.36% | 0,00 |
|
Net income Million EUR | Released Forecast Spread | -48,2 -46,7 -3.17% | -64,1 -48,9 -31.15% | -62,9 -56,2 -11.98% | -71,5 -81,0 11.76% | -47,7 |
|
EPS EUR | Released Forecast Spread | -0,94 -0,89 -5.38% | -1,14 -0,88 -30.29% | -1,11 -1,05 -6.22% | -1,26 -1,33 5.26% | -0,79 |
| Announcement Date | 28/02/19 | 05/03/20 | 25/02/21 | 24/02/22 | 23/02/23 |
Quarterly results
| Fiscal Period | December | 2019 S1 |
|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 17,3 20,0 -13.51% |
|
EBIT Million EUR | Released Forecast Spread | -26,7 -26,2 -1.85% |
| Announcement Date | 05/09/19 |
| 30/04/2024 | INARI MEDICAL, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | IRADIMED CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | NOVOCURE LIMITED: Q1 2024 Earnings Release |
| 06/05/2024 | SHOCKWAVE MEDICAL, INC.: Q1 2024 Earnings Release |
| 07/05/2024 01:39 am | SI-BONE, INC.: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | MASIMO CORPORATION: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | TREACE MEDICAL CONCEPTS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | PENUMBRA, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | CHEMOMETEC A/S: Q3 2024 Earnings Release |
| 09/05/2024 | WON TECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
Past sector events for Biocartis Group NV
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BCART Stock
- Calendar Biocartis Group NV
